Pharma giant Novo licenses Chinese weight-loss drug

T1Covered by 1 source · first reported by Semafor (filter tech) at 30 Sept, 10:58 UTC

Novo’s agreement with Hengrui Pharma, which struck an even bigger deal with GSK last year, highlights the rapid advances in China’s cutting-edge biotech sector.

science

Sources

• T1Pharma giant Novo licenses Chinese weight-loss drugSemafor (filter tech)30 Sept, 10:58